Special Meeting
Date: July 30, 2026
Time: 9:00 AM PT
Deadline to Register*: June 28, 2026 at 5pm PT
*Note: You must register by the deadline to be
eligible to participate in the meeting.
View our Special Meeting Proxy Statement
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by dialing 866-230-8457.
Date: July 30, 2026
Time: 9:00 AM PT
Deadline to Register*: June 28, 2026 at 5pm PT
*Note: You must register by the deadline to be
eligible to participate in the meeting.
Our report on activities & financial performance throughout the year.
Information about our annual meeting & matters to be voted upon.
Request paper copies of the proxy materials online now, by email or by phone by dialing
866-648-8133.
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with these rare diseases.